SPY441.40-4.34 -0.97%
DIA345.64-1.80 -0.52%
IXIC15,043.97-137.96 -0.91%

BRIEF-Coherus And Junshi Biosciences Submit Rolling BLA To FDA For Nasopharyngeal Carcinoma Treatment

reuters.com · 09/01/2021 08:12
BRIEF-Coherus And Junshi Biosciences Submit Rolling BLA To FDA For Nasopharyngeal Carcinoma Treatment

- Coherus BioSciences Inc CHRS:

  • COHERUS AND JUNSHI BIOSCIENCES ANNOUNCE COMPLETION OF ROLLING BLA SUBMISSION TO U.S. FDA FOR TORIPALIMAB FOR THE TREATMENT OF NASOPHARYNGEAL CARCINOMA

Source text for Eikon: ID:nGNX9b612W

Further company coverage: CHRS


((Reuters.Briefs@thomsonreuters.com;))